Literature DB >> 6720435

Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.

G A Taylor, A L Jackman, A H Calvert, K R Harrap.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6720435     DOI： 10.1007/978-1-4757-0390-0_72

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  3 in total

Review 1.  Clinical and preclinical pharmacokinetics of raltitrexed.

Authors:  S J Clarke; P J Beale; L P Rivory
Journal:  Clin Pharmacokinet       Date:  2000-12       Impact factor: 6.447

Review 2.  The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.

Authors:  Sridhar Nimmagadda; Anthony F Shields
Journal:  Cancer Metastasis Rev       Date:  2008-12       Impact factor: 9.264

3.  Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport.

Authors:  P G Smith; E Marshman; D R Newell; N J Curtin
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.